Principal Securities, Inc.

Source: SEC Form 13F · as of Mar 2026

Principal Securities, Inc. holds 43 biotech & pharma companies tracked by BioSniper, totaling $162.9M in value as of Mar 2026 (SEC Form 13F).

Companies held

43

Total value held

$162.9M

CompanySharesValue
LLYELI LILLY & Co23,156$21.3M
JNJJOHNSON & JOHNSON66,416$16.2M
PMPhilip Morris International Inc82,184$13.6M
ABBVAbbVie Inc.58,517$12.7M
MRKMerck & Co., Inc.72,670$8.7M
UNHUnitedHealth Group Incorporated Common Stock (DE)25,449$6.9M
AMGNAMGEN INC18,963$6.7M
ELVElevance Health Inc.20,959$6.1M
AZNASTRAZENECA PLC30,501$6.0M
CORCencora Inc.18,564$5.8M
ABTABBOTT LABORATORIES52,425$5.4M
MCKMcKesson Corporation6,046$5.2M
IQVIQVIA Holdings Inc.29,713$5.1M
NVSNovartis AG31,464$4.8M
GILDGILEAD SCIENCES, INC.29,286$4.1M
BMYBRISTOL MYERS SQUIBB CO62,512$3.8M
PFEPFIZER INC122,982$3.5M
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)55,574$3.1M
VRTXVERTEX PHARMACEUTICALS INC / MA6,578$2.9M
ZTSZoetis Inc.16,902$2.0M
GMOptec International, Inc.26,741$2.0M
SNYSanofi39,152$1.9M
CAHCardinal Health Inc.8,717$1.8M
RPRXRoyalty Pharma plc34,865$1.7M
DGXQuest Diagnostics Incorporated8,379$1.6M
IDXXIDEXX LABORATORIES INC /DE2,505$1.4M
NVONovo Nordisk A/S32,637$1.2M
CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.6,500$1.1M
ARGXARGENX SE1,259$919K
ALNYALNYLAM PHARMACEUTICALS, INC.2,745$908K
INSMINSMED Inc5,265$861K
REGNREGENERON PHARMACEUTICALS, INC.950$734K
UTHRUNITED THERAPEUTICS Corp762$452K
GEHCGE HealthCare Technologies Inc.5,436$387K
BAXBaxter International Inc.17,083$287K
ALHCAlignment Healthcare Inc.16,261$287K
BIIBBIOGEN INC.1,420$260K
HALOHALOZYME THERAPEUTICS, INC.3,878$251K
MMSIMerit Medical Systems Inc.3,454$238K
NBIXNEUROCRINE BIOSCIENCES INC1,534$202K
LGNDLigand Pharmaceuticals Incorporated1,010$202K
ARRYARRAY BIOPHARMA INC13,896$100K
BHCBausch Health Companies Inc.17,030$92K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Principal Securities, Inc. — Biotech 13F Holdings & Portfolio | BioSniper